Tuesday, November 14, 2006 6:45:00 AM PDT | VentureDeal Staff
RADNOR, PA -- Yaupon Therapeutics, a company that develops small molecule therapies for lymphoma, addiction and neuropathic pain, has announced a Series B funding of $4 million. Osage Ventures of Bala Cynwyd led the round, with additional investment by BioAdvance Greenhouse Fund, Ben Franklin Technology Partners and TDH Capital. The company's business model is to license and advance pharmaceuticals from under-served academic laboratories.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
